Heparin sodium
Sponsors
Laboratório Químico Farmacêutico Bergamo Ltda., Perosphere Pharmaceuticals Inc, a wholly owned subsidiary of AMAG Pharmaceuticals, Inc., China Medical University, China, Adiyaman University Research Hospital, Beijing Tiantan Hospital
Conditions
Acute Kidney InjuryArteriovenous MalformationsBleedingCardiac SurgeryCentral Venous Catheter ThrombosisCerebral AneurysmChronic Renal FailureCovid19
Phase 1
Evaluation of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamic Effects of PER977 Following Heparin
CompletedNCT02206087
Start: 2014-06-30End: 2016-03-31Updated: 2020-05-21
Bivalirudin vs Heparin in ECMO Patients
WithdrawnNCT03707418
Start: 2021-04-30End: 2021-06-30Updated: 2021-01-19
Enriched Heparin Anti COVID-19 Trial
CompletedNCT04743011
Start: 2021-06-01End: 2021-12-31Updated: 2024-10-15
Phase 2
Phase 3
Study of Clinical Non-inferiority of Actparin® (Laboratorio Bergamo) Compared to Heparin Sodium (APP Pharmaceuticals), in Patients With Chronic Renal Failure
NCT01346215
Start: 2011-10-31End: 2012-02-29Target: 132Updated: 2011-05-02
Efficacy and Safety of Unfractionated Heparin on Severe Sepsis With Suspected Disseminated Intravascular Coagulation
NCT02654561
Start: 2018-04-12End: 2025-06-30Target: 600Updated: 2023-11-18
Phase 4
The Effect of Heparinization Due to LBW
NCT03113708
Start: 2017-04-30End: 2017-06-20Target: 50Updated: 2017-04-14
Taurolock Hep 500 Versus Unfractionated Heparin as Anti-inflammatory in Hemodialysis Catheters.
NCT03539718
Start: 2018-05-15End: 2019-02-28Target: 60Updated: 2018-05-29
Nebulized Heparin in Severe Acute Respiratory Syndrome COVID-19
NCT04530578
Start: 2020-06-01End: 2021-06-01Target: 200Updated: 2020-08-31
Heparin-free Extracorporeal Membrane Oxygenation Support During Clinical Lung Transplantation
NCT05697692
Start: 2022-12-20End: 2024-06-30Target: 80Updated: 2023-01-26
Oxidative Stress and Circulating Nuclear DNA (cfDNA) in Acute Kidney Injury and Continuous Renal Replacement Therapies.
TerminatedNCT06646328
Start: 2018-06-09End: 2021-04-30Updated: 2024-10-18
Unknown Phase
Exploration of Anticoagulation Program in Cerebral Aneurysm and Arteriovenous Malformations With Hybrid Operation 2
NCT03306836
Start: 2016-09-30End: 2021-08-31Target: 408Updated: 2017-10-11
Continuous Heparin Infusion to Prevent Catheter-related Thrombosis
CompletedNCT04767113
Start: 2021-03-01End: 2022-08-31Updated: 2022-09-02
Effect of Different Heparinization Schemes on Prognosis of Intracranial Aneurysm
NCT05749393
Start: 2023-04-30End: 2024-04-01Target: 90Updated: 2023-12-22